aTYR PHARMA INC Common Stock, Capital Shares Reserved for Future Issuance
aTYR PHARMA INC (ATYR) had Common Stock, Capital Shares Reserved for Future Issuance of 20.85 million shares as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-07
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 20.85M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 16.88M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 16.95M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 17.10M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 20.85M shares 10-Q · filed 2026-08-07 | |
| 2026-03-31 | 16.88M shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 16.95M shares 10-K · filed 2026-03-05 | |
| 2025-09-30 | 17.10M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 17.10M shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 12.14M shares 10-Q · filed 2025-05-07 | |
| 2024-12-31 | 11.86M shares 10-K · filed 2025-03-13 | |
| 2024-09-30 | 11.90M shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 11.75M shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 8.79M shares 10-Q · filed 2024-05-02 | |
| 2023-12-31 | 8.81M shares 10-K · filed 2024-03-14 | |
| 2023-09-30 | 8.86M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 8.86M shares 10-Q · filed 2023-08-09 | |
| 2023-03-31 | 4.93M shares 10-Q · filed 2023-05-09 | |
| 2022-12-31 | 4.95M shares 10-K · filed 2023-03-14 | |
| 2022-09-30 | 4.97M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 4.97M shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 2.22M shares 10-Q · filed 2022-05-10 | |
| 2021-12-31 | 1.93M shares 10-K · filed 2022-03-15 | |
| 2021-09-30 | 1.79M shares 10-Q · filed 2021-11-12 | |
| 2021-06-30 | 1.80M shares 10-Q · filed 2021-08-11 | |
| 2021-03-31 | 1.05M shares 10-Q · filed 2021-05-14 | |
| 2020-12-31 | 1.06M shares 10-K · filed 2021-03-24 | |
| 2020-09-30 | 1.06M shares 10-Q · filed 2020-11-13 | |
| 2020-03-31 | 714.47K shares 10-Q · filed 2020-05-12 | |
| 2019-12-31 | 1.30M shares 10-K · filed 2020-03-26 | |
| 2019-09-30 | 1.77M shares 10-Q · filed 2019-11-14 | |
| 2019-06-30 | 1.06M shares 10-Q · filed 2020-08-13 | 2.07M shares 10-Q · filed 2019-08-14 |
| 2019-03-31 | 23.90M shares 10-Q · filed 2019-05-14 | |
| 2018-12-31 | 25.66M shares 10-K · filed 2019-03-26 | |
| 2018-09-30 | 25.74M shares 10-Q · filed 2018-11-14 | |
| 2018-06-30 | 25.55M shares 10-Q · filed 2018-08-14 | |
| 2018-03-31 | 25.58M shares 10-Q · filed 2018-05-15 | |
| 2017-12-31 | 24.13M shares 10-K · filed 2019-03-26 | |
| 2017-09-30 | 24.16M shares 10-Q · filed 2017-11-14 | |
| 2017-06-30 | 6.26M shares 10-Q · filed 2017-08-14 | |
| 2017-03-31 | 6.28M shares 10-Q · filed 2017-05-11 | |
| 2016-12-31 | 5.13M shares 10-K · filed 2018-03-20 | |
| 2016-09-30 | 6.05M shares 10-Q · filed 2016-11-14 | |
| 2016-06-30 | 5.90M shares 10-Q · filed 2016-08-10 | |
| 2016-03-31 | 6.93M shares 10-Q · filed 2016-05-11 | |
| 2015-12-31 | 3.78M shares 10-K · filed 2017-03-16 | 4.77M shares 10-K · filed 2016-03-30 |
| 2015-09-30 | 3.81M shares 10-Q · filed 2015-11-10 | |
| 2015-06-30 | 3.81M shares 10-Q · filed 2015-08-12 | |
| 2015-03-31 | 21.06M shares 10-Q · filed 2015-06-18 | |
| 2014-12-31 | 11.05M shares 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |